Amphastar Pharmaceuticals Goodwill and Intangible Assets 2012-2024 | AMPH

Amphastar Pharmaceuticals goodwill and intangible assets from 2012 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Amphastar Pharmaceuticals Annual Goodwill and Intangible Assets
(Millions of US $)
2023 $613
2022 $37
2021 $39
2020 $41
2019 $41
2018 $42
2017 $45
2016 $50
2015 $40
2014 $43
2013 $40
2012 $42
2011 $0
2009 $
Amphastar Pharmaceuticals Quarterly Goodwill and Intangible Assets
(Millions of US $)
2024-06-30 $601
2024-03-31 $607
2023-12-31 $613
2023-09-30 $619
2023-06-30 $626
2023-03-31 $37
2022-12-31 $37
2022-09-30 $37
2022-06-30 $38
2022-03-31 $38
2021-12-31 $39
2021-09-30 $39
2021-06-30 $40
2021-03-31 $40
2020-12-31 $41
2020-09-30 $40
2020-06-30 $40
2020-03-31 $40
2019-12-31 $41
2019-09-30 $41
2019-06-30 $42
2019-03-31 $42
2018-12-31 $42
2018-09-30 $43
2018-06-30 $43
2018-03-31 $45
2017-12-31 $45
2017-09-30 $46
2017-06-30 $46
2017-03-31 $46
2016-12-31 $50
2016-09-30 $52
2016-06-30 $43
2016-03-31 $44
2015-12-31 $40
2015-09-30 $40
2015-06-30 $41
2015-03-31 $41
2014-12-31 $43
2014-09-30 $43
2014-06-30 $39
2014-03-31 $40
2013-12-31 $40
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $42
2012-09-30
2012-06-30
2012-03-31
2011-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.438B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.120B 6.83
Dr Reddy's Laboratories (RDY) India $13.079B 19.59
BridgeBio Pharma (BBIO) United States $5.045B 0.00
Bausch Health Cos (BHC) Canada $2.956B 2.23
Supernus Pharmaceuticals (SUPN) United States $1.771B 357.00
Taysha Gene Therapies (TSHA) United States $0.449B 73.00
Personalis (PSNL) United States $0.315B 0.00
Assembly Biosciences (ASMB) United States $0.117B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00